X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2023/03/16/2629175/0/en/Rani-Therapeutics-to-Report-Fourth-Quarter-and-Full-Year-2022-Financial-Results-and-Business-Updates.html
https://www.fiercepharma.com/pharma/celltrion-signs-support-ranis-oral-biosimilar-copy-jjs-stelara-lands-right-first-negotiation
https://www.globenewswire.com//news-release/2023/01/05/2584110/0/en/Rani-Therapeutics-Receives-Feedback-from-Pre-IND-Meeting-with-FDA-Provides-Pipeline-Update.html
https://www.globenewswire.com//news-release/2022/12/06/2568782/0/en/Rani-Therapeutics-Announces-Repeat-Dose-Topline-Results-from-RT-102-Phase-1-Study.html
https://www.globenewswire.com/news-release/2022/11/09/2552427/0/en/Rani-Therapeutics-to-Present-at-the-Stifel-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2022/10/24/2539982/0/en/Rani-Therapeutics-Announces-New-RT-111-Development-Program-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2022/09/06/2510893/0/en/Rani-Therapeutics-to-Present-at-the-H-C-Wainwright-24th-Annual-Global-Investment-Conference.html
https://www.globenewswire.com/news-release/2022/08/12/2497289/0/en/Rani-Therapeutics-Announces-Termination-of-Public-Offering-of-Class-A-Common-Stock.html
https://www.globenewswire.com/news-release/2022/08/10/2496257/0/en/Rani-Therapeutics-Announces-Proposed-Public-Offering-of-Class-A-Common-Stock.html
https://www.globenewswire.com/news-release/2022/08/10/2496212/0/en/Rani-Therapeutics-Reports-Second-Quarter-2022-Financial-Results-Provides-Corporate-Update.html
Market Place
Share 
